Report Scope:
The report offers an exhaustive description and evaluation of the global stress management market. It provides in-depth qualitative and quantitative insights into the report, which aligns with the goals and objectives of our intended customers. The projections are verified through intensive primary and secondary research. The report will enable clients to obtain investment in the stress management industry on the basis of the current business scenario, trends and futuristic development in the segments. Keeping in mind the client's needs, the report provides expert insights into the global stress management industry, its services and market trends. The market is forecasted through a bottom-up approach, which includes evaluation of the market through revenues generated by the key vendors of the market. It consists of market statistics that are unveiled by affirmed private publishers and various public organizations. The data encompasses the vogue and the newest industry players along with their pre-eminent company profiles. The information is thoroughly examined through extensive primary and secondary research carried by the research analysts.
The global stress management market has been segmented on the basis of mode of treatment, end user and age group. Geographically, the market has been divided into North America, Europe, Asia-Pacific (APAC) and the Rest of the World (RoW). A country-specific breakdown of the market is also included in the report. The study covers the global stress management market irrespective of the included countries. Countries were included mainly on the basis of total revenue generated. Major countries included in the report are the U.S., Canada, Germany, the U.K., Spain, Italy, France, China, Japan, South Korea and India. Sales data for the global and regional markets were corroborated for the present and forecasted values based on statistical analysis.
Estimated values used are based on market players' total revenues and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation. Annual reports and forward-looking statement of stress management market players, annual sales of market players and average cost of software and services are considered for market estimations. A large number of stress management market players and potential startups are profiled in the report for a better understanding of the market.
The report on the stress management market provides a market overview, assesses modes of treatment, provides an end-user analysis, and analyzes the stress management market by mode of treatment, age group and end user. The major companies that were profiled in the report includes a detailed introduction, product portfolios and recent developments. The report also includes regulatory aspects, current and developing technologies, market projections, and market shares.
Report Includes:
- 52 tables
- Detailed study and industry analysis of the global stress management market
- Analyses of the global market trends with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024
- A broad range of psychotherapies and techniques that are aimed at controlling the level of stress in individuals, primarily chronic stress along with several drugs and devices, available in the market for the treatment of stress
- Data corresponding to number of cases of work-related stress, depression or anxiety; as well as the prevalence and incidence rates
- Elaboration on the role of regulatory protocols, current and developing technologies, and other macroeconomic factors shaping the stress management marketplace
- Profile description of market leading companies, their product portfolios and recent developments, including Abbott Laboratories Inc., Eli Lilly and Co., GlaxoSmithKline PLC, Lupin Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc. and Takeda Pharmaceutical Co., Ltd.
Summary
The global stress management market is projected to grow at a modest CAGR of REDACTED, during the forecast period (2019 to 2024). The market was valued at REDACTED in 2018, and is estimated to reach REDACTED in 2024. Stress management includes a broad range of drugs and medications, psychotherapies, and techniques that are aimed at controlling the level of stress in individuals, primarily chronic stress. Several drugs and devices are available for the treatment of stress among patients. Some antidepressants that are commonly used for the treatment of stress disorders include Prozac, Lexapro, Paxil, Zoloft and Celexa. These drugs are used for the treatment of stress disorders, includinggeneralized anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD). The therapy and devices available for the treatment of patients suffering from stress disorders include deep brain stimulation, Alpha-Stim, transcranial magnetic stimulation and wearable devices. Deep brain stimulation (DBS) is being utilized for the treatment of OCD which is non-responsive to medication. The device used in the DBS procedure targets specific areas of the brain that are involved in OCD, including the subthalamic nucleus, the anterior limb of the internal capsule, the nucleus accumbens and the inferior thalamic nucleus. As the stress level is increasing among adults and the elderly population, the adoption of stress management therapies is expected to grow significantly to reduce the stress level among individuals.
The global stress management market is expected to show potential growth during the forecast period. The major factors that are primarily driving the growth of the market include increased levels of stress at the workplace, emerging awareness regarding stress management and growing insurance claims for mental health. For instance, in Great Britain, the prevalence of anxiety, stress and depression is very high, majorly in public service industries; including education, health and social care; and public administration and defense. By occupation, professionals that are common across public service industries (such as healthcare workers; teaching professionals and public service professionals) show
higher levels of stress as compared to all other professionals. According to the Health and Safety Executive (HSE) in Great Britain, the total number of cases of work-related stress, depression or anxiety was 602,000, a prevalence rate of 1,800 per 100,000 workers in 2018. Among which, the number of new cases was 246,000, an incidence rate of 740 per 100,000 workers.
Likewise, an increased level of stress has been reported in the U.S. For instance, as per the American Institute of Stress (AIS), several studies demonstrated that job stress is the key source of stress among adults in the U.S., which has even intensified over the years. The major causes of stress at the workplace in the U.S. include a lack of job security, workload, and concerns with coworkers. These growing stress concerns have led the demand for stress management therapies that can minimize the level of stress and enable individuals to live a healthier and fuller life. Normally, drugs are used to dampen down the hormonal stress response system; which thereby facilitates cortisol levels to return to a normal level. As a result, it rescues brain cells from the stress effects. Therefore, drug therapies are considered as the foremost treatment for stress conditions, including generalized anxiety disorder and OCD.
Stress Management Industry: Global Trends
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Market Trends
Antidepressant Demand Slows
Europe Dominates the Global Stress Management Market
Government Awareness Campaigns for Mental Health
Emerging Focus on Transcranial Magnetic Stimulation for Depression
Introduction of New Apps for Stress Management
Potential Growth of Off-Label Stress Reducers Such as ASMR
Market Dynamics
Factors Driving the Growth of the Market
Restraints
Chapter 4 Market Breakdown by Treatment Type
Drugs and Medications
Antidepressant Drugs
Atypical Antipsychotics
Beta-Blockers
Others (Benzodiazepines)
Therapies and Devices
Deep Brain Stimulation
Transcranial Magnetic Stimulation
Vagus Nerve Stimulation
Wearable Devices and Apps
ASMR (Autonomous Sensory Meridian Response)
Chapter 5 Market Breakdown by End User
Hospitals
Ambulatory Surgical Centers
Others
Chapter 6 Market Breakdown by Age Group
Children
Adults
Elderly
Chapter 7 Market Breakdown by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Brazil
Mexico
South Africa
Chapter 8 Patent Review/New Developments
Chapter 9 Analysis of Market Opportunities
Increasing Adoption of Wearables and Smart Devices for Stress Relief
Significant FDA Approvals for Neurological Therapies
Recent FDA Approvals
Key Suppliers and Manufacturers
Eli Lilly and Co.
Otsuka Holding Co., Ltd.
H. Lundbeck A/S
Johnson & Johnson Services Inc.
AstraZeneca PLC
Strategies
Product Launches and Approvals
Collaborations and Partnerships
Geographical Expansion
Chapter 10 Company Profiles
ABBOTT LABORATORIES INC.
ALKERMES PLC
ALLERGAN PLC
APPLE INC.
ASTRAZENECA PLC
AZUMIO INC.
BAUSCH HEALTH COMPANIES INC.
BEIJING PINS MEDICAL CO., LTD.
BIOCONTROL MEDICAL LTD.
BRAINSWAY LTD.
BRISTOL-MYERS SQUIBB CO.
CAEDEN INC.
DARTA SYSTEMS
DEVON MEDICAL PRODUCTS INC.
ELECTROMEDICAL PRODUCTS INTERNATIONAL INC.
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE AG
FACEMETRICS LTD.
FISHER WALLACE LABORATORIES INC.
FITBIT INC.
GARMIN LTD.
GLAXOSMITHKLINE PLC
H. LUNDBECK A/S
HEADSPACE INC.
IBREVE LTD.
INTERAXON INC.
JOHNSON & JOHNSON SERVICES INC.
LIEF THERAPEUTICS
LIVANOVA PLC
LUPIN LTD.
MAG & MORE GMBH
MAGVENTURE INC.
MERCK & CO. INC.
MOOD TRACKER WEB MEDIA LLC
MYLAN N.V.
NEURONETICS INC.
NEUROSIGMA INC.
NEUVANA LLC
OTSUKA PHARMACEUTICAL CO., LTD.
PFIZER INC.
SAMSUNG ELECTRONICS CO., LTD.
SANVELLO HEALTH INC.
SPIRE INC.
TAKEDA PHARMACEUTICAL CO., LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
THYNC GLOBAL INC.
TINGLES INC.
WALDEN MEDICAL NEURO DIGITAL THERAPIES LLC
List of Tables
Summary Table : Global Market for Stress Management Treatments, by Type, Through 2024
Table 1 : Source of Stress Related to Specific Job Type
Table 2 : Most Common SSRIs and Their Side Effects
Table 3 : Global Market for Stress Management Treatments, by Type, Through 2024
Table 4 : Global Market for Stress Management Treatments, by Drug Type, Through 2024
Table 5 : Major Drug Classes Used in the Treatment of Stress-Associated Disorders
Table 6 : Global Market for Drugs and Medications Used for Stress Management, by Region, Through 2024
Table 7 : FDA Approved Antidepressants
Table 8 : Details of Atypical Antipsychotic Drugs
Table 9 : Global Market for Therapies and Devices Used in Stress Management, by Type, Through 2024
Table 10 : Global Market for Therapies and Devices Used in Stress Management, by Region, Through 2024
Table 11 : Wearable Devices and Apps Used for Stress Management
Table 12 : Global Market for Stress Management Treatments, by End User, Through 2024
Table 13 : Common Stress Management Services Offered in Hospitals
Table 14 : Global Market for Stress Management Treatments in Hospitals and Clinics, by Region, Through 2024
Table 15 : Global Market for Stress Management Treatments in Ambulatory Surgical Centers, by Region, Through 2024
Table 16 : Global Market for Stress Management Treatments in Other End Uses, by Region, Through 2024
Table 17 : Global Market for Stress Management Treatments, by Age Group, Through 2024
Table 18 : Global Market for Stress Management Treatments for Children, by Region, Through 2024
Table 19 : Major Causes of Stress Among Adults in the U.S.
Table 20 : Global Market for Stress Management Treatments for Adults, by Region, Through 2024
Table 21 : Global Market for Stress Management Treatments for the Elderly, by Region, Through 2024
Table 22 : Global Market for Stress Management Treatments, by Region, Through 2024
Table 23 : North American Market for Stress Management Treatments, by Type, Through 2024
Table 24 : North American Market for Stress Management Treatments, by End User, Through 2024
Table 25 : North American Market for Stress Management Treatments, by Age Group, Through 2024
Table 26 : North American Market for Stress Management Treatments, by Country, Through 2024
Table 27 : Canada's Mental Health Resources, 2017
Table 28 : European Market for Stress Management Treatments, by Type, Through 2024
Table 29 : European Market for Stress Management Treatments, by End User, Through 2024
Table 30 : European Market for Stress Management Treatments, by Age Group, Through 2024
Table 31 : European Market for Stress Management Treatments, by Country, Through 2024
Table 32 : Germany's Mental Health Resources, 2017
Table 33 : France's Mental Health Resources, 2017
Table 34 : Italy's Mental Health Resources, 2017
Table 35 : Spain's Mental Health Resources, 2017
Table 36 : Asia-Pacific Market for Stress Management Treatments, by Type, Through 2024
Table 37 : Asia-Pacific Market for Stress Management Treatments, by End User, Through 2024
Table 38 : Asia-Pacific Market for Stress Management Treatments, by Age Group, Through 2024
Table 39 : Asia-Pacific Market for Stress Management Treatments, by Country, Through 2024
Table 40 : China's Mental Health Resources, 2017
Table 41 : India's Mental Health Resources, 2017
Table 42 : Rest of the World Market for Stress Management Treatments, by Type, Through 2024
Table 43 : Rest of the World Market for Stress Management Treatments, by End User, Through 2024
Table 44 : Rest of the World Market for Stress Management Treatments, by Age Group, Through 2024
Table 45 : Patents on Stress Management Treatments, by Category in Different Countries, January 2016-August 2019
Table 46 : Distribution of Major Patents on Stress Management Treatments, by Assignee, January 2016-December 2019
Table 47 : Total Patents Analyzed for Stress Management Treatments, January 2016-December 2019
Table 48 : Eli Lilly and Co.: Product Sales, by Country/Region, 2018
Table 49 : Otsuka Pharmaceutical's Clinical Trials on Stress Management Treatments
Table 50 : H. Lundbeck: Product Sales, 2017 and 2018
Table 51 : Johnson & Johnson: Revenue Generated from Drugs Used in the Treatment of Depression, 2017 and 2018
List of Figures
Summary Figure : Global Market for Stress Management Treatments, by Type, 2018-2024
Figure 1 : Breakdown of Mental Health-Related Insurance Claims, 2012-2017
Figure 2 : Share of Claims Tied to Generalized Anxiety Disorder Among Young People, 2014-2017
Figure 3 : Global Distribution of Diseases Causing Loss of Work Output, by Disease Type, 2018
Figure 4 : Global Incidence of Major Depressive Disorder, by Region, 2015-2017
Figure 5 : Behavioral Changes in Children: Depression and Anxiety, by Age Group, 2015
Figure 6 : Incidence of Anxiety Disorders in North America, 2013-2017
Figure 7 : Prevalence of Depressive Disorder in the U.S., 2013-2017
Figure 8 : Number of Clinical Studies Based on Trauma, by Type, 1988-2018
Figure 9 : Prevalence of Depressive Disorder in Canada, 2013-2017
Figure 10 : Regional European Shares of Populations with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 11 : Percentage of U.K.'s Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 12 : Percentage of Germany's Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 13 : Percentage of France's Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 14 : Percentage of Italy's Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 15 : Percentage of Spain's Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 16 : Percentage of Asia-Pacific's Population with Depression, by Country, 2017
Figure 17 : Percentage of China's Population with Behavioral Health Disorders, by Type of Disorder, 2015-2017
Figure 18 : Percentage of India's Population with Behavioral Health Disorders, by Type of Disorder, 2015-2017
Figure 19 : Percentage of Japan's Population with Behavioral Disorders, by Type of Disorder, 2017
Figure 20 : Percentage of Australia's Population with Behavioral Disorders, by Type of Disorder, 2017
Figure 21 : Prevalence of Major Stress Disorders in Latin America, by Type of Disorder, 2015-2017
Figure 22 : Prevalence of Major Stress Disorders in Brazil, by Type of Disorder, 2015-2017
Figure 23 : Prevalence of Stress Disorders in Mexico, by Type of Disorder, 2015-2017
Figure 24 : Prevalence of Major Stress Disorders in South Africa, by Type of Disorder, 2015-2017
Global Surgical Overalls Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Surgical Overalls market was valued at US$ 679.9 million in 2023 and is anticipated to reach US$ 870.5 million by 2030, witnessing a CAGR of 3.1% during The forecast period 2024-2030.
According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in recent years ......
Global Medical or Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Medical or Healthcare market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical or Healthcare is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Medical or Healthcare market. Medical or Healthcare are expected to show stable growth in the future market. However, product differ......
Global Hospital Gas Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 100
According to our LPI (LP Information) latest study, the global Hospital Gas market size was valued at US$ million in 2023. With growing demand in downstream market, the Hospital Gas is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hospital Gas market. Hospital Gas are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Nurse Call Systems Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 135
According to our LPI (LP Information) latest study, the global Nurse Call Systems market size was valued at US$ 1633.1 million in 2023. With growing demand in downstream market, the Nurse Call Systems is forecast to a readjusted size of US$ 3280.4 million by 2030 with a CAGR of 10.5% during review period.
The research report highlights the growth potential of the global Nurse Call Systems market. Nurse Call Systems are expected to show stable growth in the future market. However, product......
Global Pediatric Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 118
According to our LPI (LP Information) latest study, the global Pediatric Healthcare market size was valued at US$ 136230 million in 2023. With growing demand in downstream market, the Pediatric Healthcare is forecast to a readjusted size of US$ 177330 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Pediatric Healthcare market. Pediatric Healthcare are expected to show stable growth in the future market. However, ......
Global Telepharmacy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 100
Market Overview of Global Telepharmacy market:
According to our latest research, the global Telepharmacy market looks promising in the next 5 years. As of 2022, the global Telepharmacy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Telepharmacy market, with a systema......
Global Vinca Alkaloid Compounds Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Vinca Alkaloid Compounds market:
According to our latest research, the global Vinca Alkaloid Compounds market looks promising in the next 5 years. As of 2022, the global Vinca Alkaloid Compounds market was estimated at USD 26.93 million, and it's anticipated to reach USD 44.76 million in 2028, with a CAGR of 8.84% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of th......
Global Bladder Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 116
Market Overview of Global Bladder Cancer market:
According to our latest research, the global Bladder Cancer market looks promising in the next 5 years. As of 2022, the global Bladder Cancer market was estimated at USD 3886.47 million, and it's anticipated to reach USD 13709.57 million in 2028, with a CAGR of 23.38% during the forecast years.
Bladder cancer is a disease in which cells in the urinary bladder start growing abnormally and uncontrollably. The main types of bladde......
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market:
According to our latest research, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market looks promising in the next 5 years. As of 2022, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
